Exactech Secures $85M in Funding to Revolutionize Orthopaedic Surgery

In a significant move to advance its mission of restoring mobility to patients, Exactech, a global leader in medical technology, has successfully raised $85 million in a recent funding round. Renowned for providing orthopaedic surgeons with cutting-edge implants and surgical instruments, Exactech is also at the forefront of harnessing smart technologies through its Active Intelligence® (AI) ecosystem. This latest infusion of capital will be instrumental in accelerating the development and commercialization of innovative solutions that empower surgeons in their quest to improve patient outcomes. The funding will specifically target enhancements in Exactech's product portfolio, including next-generation implants that foster a more targeted and effective surgical approach. Moreover, the company aims to expand its AI capabilities, ensuring that surgeons have access to real-time data and analytics that can inform their decisions during procedures. Exactech's commitment to innovation not only underscores its reputation as a pioneer in orthopaedic solutions but also highlights its dedication to delivering exactly what patients need to regain mobility and improve their quality of life. With this substantial investment, the company is poised to solidify its presence in the global medical landscape, pushing the boundaries of what is possible in orthopaedic surgery. For more information about Exactech and its groundbreaking technologies, visit www.exac.com. As always, Exactech encourages vigilance against cybersecurity threats and wants to remind the public that it never solicits interviews through text message or asks for sensitive personal information.